Mintz Washington, D.C. Member and health care and life sciences litigator Larry Freedman is quoted in this Bloomberg BNA Health Care Daily Report article on the U.S. Supreme Court ruling’s impact on False Claims Act (FCA) liability in the Escobar case. The article notes that the ruling held that “the implied false certification theory of FCA liability is valid but must meet rigorous materiality standards to support claims through regulatory violations.”